Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MYO3A

RBC: MYO3A · Substrate: MBP ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Ponatinib93.40.53
Brigatinib84.90.51
Gilteritinib81.30.51
Ceritinib79.40.62
Midostaurin58.00.50
Alectinib52.10.65
Vemurafenib50.40.60
Netarsudil41.60.68
Abemaciclib32.90.56
Sunitinib27.50.52
Osimertinib27.20.73
Defactinib24.70.45
Abrocitinib21.50.58
Ripretinib20.90.67
Tivozanib20.00.67

Known variants

No variants catalogued.
Open in new tab